1. Home
  2. MBVI vs CYRX Comparison

MBVI vs CYRX Comparison

Compare MBVI & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBVI

M3-Brigade Acquisition VI Corp. Class A Ordinary Shares

N/A

Current Price

$10.13

Market Cap

433.8M

Sector

N/A

ML Signal

N/A

CYRX

CryoPort Inc.

HOLD

Current Price

$13.18

Market Cap

419.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBVI
CYRX
Founded
2025
1999
Country
United States
United States
Employees
N/A
1100
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
433.8M
419.3M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
MBVI
CYRX
Price
$10.13
$13.18
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$13.31
AVG Volume (30 Days)
26.0K
578.9K
Earning Date
01-01-0001
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
156.22
EPS
N/A
N/A
Revenue
N/A
$176,177,000.00
Revenue This Year
N/A
$11.06
Revenue Next Year
N/A
$8.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.99
$5.31
52 Week High
$10.18
$13.79

Technical Indicators

Market Signals
Indicator
MBVI
CYRX
Relative Strength Index (RSI) 77.13 73.04
Support Level $9.99 $7.98
Resistance Level $10.18 N/A
Average True Range (ATR) 0.01 0.69
MACD 0.00 0.15
Stochastic Oscillator 100.00 85.84

Price Performance

Historical Comparison
MBVI
CYRX

About MBVI M3-Brigade Acquisition VI Corp. Class A Ordinary Shares

M3-Brigade Acquisition VI Corp is a newly incorporated blank check company.

About CYRX CryoPort Inc.

CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.

Share on Social Networks: